Skip to main content
. 2015 Nov 14;21(42):12083–12090. doi: 10.3748/wjg.v21.i42.12083

Table 1.

Risk of de novo hepatitis B in recipients of anti-HBc-positive organs

Recipient status Naive AntiHBc+ AntiHBc+ AntiHBc-
AntiHBs- AntiHBs+ AntiHBs+
No prophylaxis > 40% 13% < 2% 10%
With prophylaxis 12% < 4% < 2% < 2%
High risk Intermediate risk Low risk Intermediate risk